We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$3.82B
AUM Growth
+$383M
Cap. Flow
-$303M
Cap. Flow %
-7.94%
Top 10 Hldgs %
17.8%
Holding
1,178
New
280
Increased
3
Reduced
68
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPACR
1026
DELISTED
Model Performance Acquisition Corp. Right
MPACR
$150K ﹤0.01%
15,000
VTAQR
1027
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$150K ﹤0.01%
15,000
GBRGR
1028
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$149K ﹤0.01%
15,000
TRTL.WS
1029
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$121K ﹤0.01%
12,500
VENAR
1030
DELISTED
Venus Acquisition Corporation Rights
VENAR
$121K ﹤0.01%
12,000
CDRO icon
1031
Codere Online
CDRO
$408M
$120K ﹤0.01%
+19,999
New +$134K
MSAC
1032
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$116K ﹤0.01%
11,883
NOAC
1033
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
$107K ﹤0.01%
10,900
VYGG.WS
1034
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$102K ﹤0.01%
10,417
VTIQW
1035
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$99K ﹤0.01%
10,183
SANBW
1036
DELISTED
Sanaby Health Acquisition Corp. I Warrant
SANBW
$99K ﹤0.01%
+10,000
New +$5.11K
GLLIR
1037
DELISTED
Globalink Investment Inc. Rights
GLLIR
$98K ﹤0.01%
+10,000
New +$2.55K
MCAGR
1038
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$98K ﹤0.01%
+10,000
New +$3.7K
AUR icon
1039
Aurora
AUR
$13.8B
-128,500
Closed -$1.28M
BZFD icon
1040
BuzzFeed
BZFD
$96.7M
-150,000
Closed -$5.95M
GPGI
1041
GPGI Inc
GPGI
$4.35B
-393,437
Closed -$3.3M
CMPOW
1042
DELISTED
CompoSecure Inc Warrant
CMPOW
-88,972
Closed -$900K
DAVE icon
1043
Dave Inc
DAVE
$4.06B
-10,034
Closed -$3.18M
DCGO icon
1044
DocGo
DCGO
$62.6M
-550,040
Closed -$5.48M
LOCL icon
1045
Local Bounti
LOCL
$23.5M
-30,769
Closed -$3.98M
NVTS icon
1046
Navitas Semiconductor
NVTS
$3.63B
-251,614
Closed -$2.51M
PIII icon
1047
P3 Health Partners
PIII
$38.5M
-12,000
Closed -$5.92M
PIIIW icon
1048
P3 Health Partners Inc Warrant
PIIIW
$179K
-192,599
Closed -$1.9M
PL icon
1049
Planet Labs
PL
$8.53B
-356,686
Closed -$3.54M
RGTI icon
1050
Rigetti Computing
RGTI
$5.99B
-261,330
Closed -$2.55M

Similar funds

Radcliffe Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Radcliffe Capital Management held 1,178 positions worth $3.82B, up 11% from $3.44B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Radcliffe Capital Management withdrew a net $303M in Q4 2021, closing 128 positions and reducing 68 holdings. Its most notable exit was Sierra Lake Acquisition Corp. Unit, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Radcliffe Capital Management opened a new position in Enphys Acquisition Corp. worth $23.8M.

  • Radcliffe Capital Management's largest Q4 2021 buy was Enphys Acquisition Corp.: 2,469,892 shares worth $23.8M.
  • Radcliffe Capital Management added most to Horizon Acquisition Corporation II in Q4 2021, an estimated $2.46M increase.
  • Radcliffe Capital Management's biggest Q4 2021 reduction was USHG Acquisition Corp., cutting an estimated $2.74M.
  • Radcliffe Capital Management fully exited Sierra Lake Acquisition Corp. Unit in Q4 2021, selling an estimated $27.9M.
  • Radcliffe Capital Management's ten largest holdings make up 18% of its $3.82B portfolio in Q4 2021.
  • Radcliffe Capital Management opened 280 new positions and closed 128 in Q4 2021.
  • Radcliffe Capital Management's portfolio value rose 11% quarter-over-quarter to $3.82B.

Based on Radcliffe Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.